Related Experiment Video
Updated: Apr 30, 2026
09:23
Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
9.8K
Factors moderating cadmium bioavailability: Key considerations for comparing blood cadmium levels between groups
Ana Cirovic1, Aleksandar Cirovic1
1Institute of Anatomy, Faculty of Medicine, University of Belgrade, Dr Subotica 4/2, Belgrade, 11000, Serbia.
Summary
Cadmium exposure poses health risks, but individual susceptibility varies. Factors like nutrient deficiencies, lung function, and liver health significantly influence cadmium levels in the body.
Area of Science:
- Environmental Health
- Toxicology
- Human Health Risk Assessment
Background:
- Cadmium (Cd) is a toxic heavy metal posing significant health risks.
- Exposure is linked to cancers, cardiovascular disease, kidney disease, and osteoporosis.
- Individual risk for Cd-related disorders is not uniform.
Purpose of the Study:
- To review factors influencing cadmium (Cd) blood levels.
- To provide a comprehensive analysis of Cd absorption and distribution.
- To highlight variables impacting Cd levels in diverse populations.
Main Methods:
- Literature review of studies on cadmium exposure and health outcomes.
- Analysis of factors affecting cadmium intestinal absorption.
- Examination of conditions altering cadmium circulation.
Main Results:
- Nutrient deficiencies (iron, zinc, calcium), anemia, COPD, and low parathyroid hormone (PTH) can increase Cd absorption.
- Chronic liver disorders can elevate circulating Cd levels.
- Age, sex, alcohol, and comorbidities significantly impact measured Cd blood levels.
Conclusions:
- Understanding factors influencing Cd blood levels is crucial for accurate risk assessment.
- Individual variability in Cd levels necessitates consideration of multiple physiological and lifestyle factors.
- Further research should integrate these variables for comprehensive Cd health impact studies.
Related Concept Videos
01:19Factors Affecting Drug Biotransformation: Biological
915
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
915
01:22Bioavailability: Influencing Factors
679
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
679
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429
01:24Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229